{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:18:20Z","timestamp":1775193500563,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ecl.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T12:13:29Z","timestamp":1560773609000},"page":"533-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Hyperthyroidism and Pregnancy"],"prefix":"10.1016","volume":"48","author":[{"given":"Kristen","family":"Kobaly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ecl.2019.05.002_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1089\/thy.1998.8.859","article-title":"Thyroid hyperfunction during pregnancy","volume":"8","author":"Glinoer","year":"1998","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ecl.2019.05.002_bib2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0002-9378(11)91565-8","article-title":"Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects","volume":"167","author":"Goodwin","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ecl.2019.05.002_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-0528.2002.01223.x","article-title":"Transient hyperthyroidism of hyperemesis gravidarum","volume":"109","author":"Tan","year":"2002","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.ecl.2019.05.002_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","article-title":"Hyperthyroidism in pregnancy","volume":"1","author":"Cooper","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2 Pt 1","key":"10.1016\/j.ecl.2019.05.002_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.AOG.0000197991.64246.9a","article-title":"Subclinical hyperthyroidism and pregnancy outcomes","volume":"107","author":"Casey","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ecl.2019.05.002_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000357615","article-title":"Pregnancy outcome in hyperthyroidism: a case control study","volume":"77","author":"Aggarawal","year":"2014","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"10.1016\/j.ecl.2019.05.002_bib7","first-page":"946","article-title":"Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism","volume":"84","author":"Millar","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9378(03)00944-X","article-title":"Thyrotoxicosis and heart failure that complicate pregnancy","volume":"190","author":"Sheffield","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ecl.2019.05.002_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF03348950","article-title":"Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy","volume":"16","author":"Glinoer","year":"1993","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3 Pt 1","key":"10.1016\/j.ecl.2019.05.002_bib10","first-page":"355","article-title":"Morning sickness and thyroid function in normal pregnancy","volume":"72","author":"Mori","year":"1988","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ecl.2019.05.002_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2265.1997.2011011.x","article-title":"The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies","volume":"46","author":"Grun","year":"1997","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4158\/EP09233.RA","article-title":"Graves' hyperthyroidism and pregnancy: a clinical update","volume":"16","author":"Patil-Sisodia","year":"2010","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.ecl.2019.05.002_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/EJE-13-0533","article-title":"Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study","volume":"169","author":"Carle","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2019.05.002_bib14","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1210\/jc.2014-3588","article-title":"Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study","volume":"100","author":"Andersen","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-55-1-108","article-title":"Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease","volume":"55","author":"Amino","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2019.05.002_bib16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jcem-57-5-1036","article-title":"Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism","volume":"57","author":"Zakarija","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2019.05.002_bib17","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1210\/jc.2003-030971","article-title":"No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves' disease","volume":"88","author":"Amino","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2019.05.002_bib18","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/thy.2013.0585","article-title":"Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow","volume":"24","author":"Ide","year":"2014","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ecl.2019.05.002_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.ecl.2019.05.002_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"1 Pt 1","key":"10.1016\/j.ecl.2019.05.002_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9378(13)70286-2","article-title":"A\u00a0comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy","volume":"170","author":"Wing","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/jcem-62-1-217","article-title":"Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests","volume":"62","author":"Gardner","year":"1986","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2019.05.002_bib23","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","author":"Mortimer","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2019.05.002_bib24","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2019.05.002_bib25","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"Andersen","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib26","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-14-0135","article-title":"Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?","volume":"171","author":"Laurberg","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2019.05.002_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/M17-1398","article-title":"Antithyroid drugs and congenital malformations: a Nationwide Korean Cohort Study","volume":"168","author":"Seo","year":"2018","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ecl.2019.05.002_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.ecl.2019.05.002_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2009.03495.x","article-title":"Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study","volume":"68","author":"Rosenfeld","year":"2009","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.ecl.2019.05.002_bib30","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1210\/jc.2010-0652","article-title":"Treatment of hyperthyroidism in pregnancy and birth defects","volume":"95","author":"Clementi","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2019.05.002_bib31","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/thy.2014.0150","article-title":"Severity of birth defects after propylthiouracil exposure in early pregnancy","volume":"24","author":"Andersen","year":"2014","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ecl.2019.05.002_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1470583","article-title":"Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease","volume":"147","author":"Nedrebo","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2019.05.002_bib33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02295","article-title":"Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198607033150104","article-title":"Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status","volume":"315","author":"Momotani","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2019.05.002_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/thy.1992.2.219","article-title":"Diagnosis and management of Graves' disease in pregnancy","volume":"2","author":"Hamburger","year":"1992","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-08-0663","article-title":"Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy","volume":"160","author":"Laurberg","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"22","key":"10.1016\/j.ecl.2019.05.002_bib37","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198111263052205","article-title":"Current concepts: beta-blockers in pregnancy","volume":"305","author":"Rubin","year":"1981","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ecl.2019.05.002_bib38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jpeds.2012.05.057","article-title":"Congenital hypothyroidism caused by excess prenatal maternal iodine ingestion","volume":"161","author":"Connelly","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"10","key":"10.1016\/j.ecl.2019.05.002_bib39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/thy.2014.0581","article-title":"Substituting potassium iodide for methimazole as the treatment for Graves' disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan","volume":"25","author":"Yoshihara","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2019.05.002_bib41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0000000000002014","article-title":"Committee opinion no. 696: nonobstetric surgery during pregnancy","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/Mirt.123","article-title":"Nuclear imaging of a pregnant patient: should we perform nuclear medicine procedures during pregnancy?","volume":"21","author":"Bural","year":"2012","journal-title":"Mol Imaging Radionucl Ther"},{"key":"10.1016\/j.ecl.2019.05.002_bib43","series-title":"Radiation protection of pregnant women in nuclear medicine","author":"International Atomic Energy Agency","year":"2018"},{"issue":"5","key":"10.1016\/j.ecl.2019.05.002_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1530\/EJE-10-1155","article-title":"Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study","volume":"164","author":"Carle","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2019.05.002_bib45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/thy.1999.9.727","article-title":"Fetal and neonatal hyperthyroidism","volume":"9","author":"Zimmerman","year":"1999","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000453065","article-title":"Management of fetal and neonatal Graves' disease","volume":"87","author":"Leger","year":"2017","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"10.1016\/j.ecl.2019.05.002_bib47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/thy.2017.0413","article-title":"Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: a systematic review","volume":"28","author":"van Dijk","year":"2018","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clp.2017.10.001","article-title":"Neonatal thyrotoxicosis","volume":"45","author":"Samuels","year":"2018","journal-title":"Clin Perinatol"},{"issue":"2","key":"10.1016\/j.ecl.2019.05.002_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2265.1990.tb00850.x","article-title":"Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function","volume":"32","author":"Mortimer","year":"1990","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2019.05.002_bib50","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1530\/eje.0.1390584","article-title":"Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association","volume":"139","author":"Laurberg","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2019.05.002_bib51","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1210\/jc.2004-2555","article-title":"Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring","volume":"90","author":"Luton","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2019.05.002_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pd.2916","article-title":"Effect of placenta penetration during cordocentesis at mid-pregnancy on fetal outcomes","volume":"32","author":"Boupaijit","year":"2012","journal-title":"Prenat Diagn"},{"issue":"3 Pt 2","key":"10.1016\/j.ecl.2019.05.002_bib53","first-page":"509","article-title":"Fetal blood sampling in the management of intrauterine thyrotoxicosis","volume":"76","author":"Porreco","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ecl.2019.05.002_bib54","first-page":"664","article-title":"Cordocentesis for diagnostic indications: two years' experience","volume":"70","author":"Weiner","year":"1987","journal-title":"Obstet Gynecol"},{"issue":"4 Pt 1","key":"10.1016\/j.ecl.2019.05.002_bib55","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/0002-9378(91)90462-Z","article-title":"Risk factors for cordocentesis and fetal intravascular transfusion","volume":"165","author":"Weiner","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ecl.2019.05.002_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198102263040907","article-title":"Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease","volume":"304","author":"Cheron","year":"1981","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2019.05.002_bib57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.beem.2004.03.009","article-title":"Fetal and neonatal thyroid function in relation to maternal Graves' disease","volume":"18","author":"Polak","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2019.05.002_bib58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/pd.685","article-title":"Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy","volume":"23","author":"Cohen","year":"2003","journal-title":"Prenat Diagn"},{"issue":"11","key":"10.1016\/j.ecl.2019.05.002_bib59","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/thy.1999.9.1111","article-title":"Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism","volume":"9","author":"Ochoa-Maya","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2019.05.002_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpeds.2018.01.071","article-title":"Prediction of neonatal hyperthyroidism","volume":"197","author":"Banige","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ecl.2019.05.002_bib61","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jcem.86.6.7573","article-title":"The use of antithyroid drugs in pregnancy and lactation","volume":"86","author":"Mandel","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2019.05.002_bib62","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1210\/jcem.85.9.6810","article-title":"Thyroid function and intellectual development of infants nursed by mothers taking methimazole","volume":"85","author":"Azizi","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:44:33Z","timestamp":1760175873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852919300313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0889852919300313"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2019.05.002","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperthyroidism and Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}